Funder: CureSearch for Children's Cancer
Due Dates: October 6, 2028 (LOI) | January 18, 2029 (Full application)
Funding Amounts: Up to $1.5 million over three years
Summary: Supports evidence-based translational and preclinical pediatric cancer research with a clear path toward clinical trials within three years.
Key Information: Full applications are accepted by invitation following Letter of Intent review.
Description
CureSearch for Children's Cancer’s Acceleration Initiative Award supports innovative, evidence-based translational and preclinical research that prepares promising pediatric cancer treatments for clinical testing. The program addresses a stage when treatment approaches can stall because researchers must build evidence and complete development work before a therapy can be tested in patients.
The three-year awards focus on significant unmet needs in pediatric cancer and projects positioned to overcome defined barriers to treatment development. The goal is to reach clinical trials within three years. Within CureSearch’s research funding strategy, the award centers on preclinical development, where safety and efficacy are evaluated before treatments advance into early clinical trials.
